SEC Form 4 · accession 0001209191-17-051325
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F MacLean
Officer — Chief Financial Officer
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.65 | Aug 31, 2017 | A | 332,708 | A | — | Aug 30, 2027 | Common Stock | 332,708 | 332,708 | D |
Explanation of responses
- F1The shares vest as follows: 1/4th of the shares vest one year after August 31, 2017; 1/48th of the shares vest monthly thereafter over the next three years.